1994
DOI: 10.1084/jem.179.3.849
|View full text |Cite
|
Sign up to set email alerts
|

Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.

Abstract: SummaryImmune complexes containing human gamma (g)l or murine g2a antibodies generate secondary erector mechanisms via Fc receptor binding or complement activation, whereas those containing human g4 or murine gl antibodies generally do not. Therefore, isotype selection of therapeutic antibodies may have important clinical consequences. In a rabbit model of recombinant human tumor necrosis factor (rhuTNF)-induced pyrexia, a murine/human chimeric g4 anti-human TNF-ot mcnoclonal antibody (mAb) (cCB0011) showed a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

1995
1995
2010
2010

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(27 citation statements)
references
References 37 publications
1
26
0
Order By: Relevance
“…One possible explanation is that the early elevation in plasma TNF caused the activation of other systems, which were responsible for the subsequent haemodynamic changes (Billiau & Vandekerckhove, 1991 (Suitters et al, 1994). Other groups have examined the effectiveness of TNF antibodies in several different models of endotoxaemia, and most reports agree that TNF antibodies are capable of reducing mortality rates in endotoxaemia (Beutler et al, 1985a;Tracey et al, 1987a;Mathison et al, 1988;Hinshaw et al, 1990;Suitters et al, 1994).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One possible explanation is that the early elevation in plasma TNF caused the activation of other systems, which were responsible for the subsequent haemodynamic changes (Billiau & Vandekerckhove, 1991 (Suitters et al, 1994). Other groups have examined the effectiveness of TNF antibodies in several different models of endotoxaemia, and most reports agree that TNF antibodies are capable of reducing mortality rates in endotoxaemia (Beutler et al, 1985a;Tracey et al, 1987a;Mathison et al, 1988;Hinshaw et al, 1990;Suitters et al, 1994).…”
Section: Discussionmentioning
confidence: 99%
“…The single doses were therefore chosen on the basis of our previous work (Gardiner et al, 1991b;1992b;Waller et al, 1994). The doses of antibodies used in the present study were chosen on the basis of previous work (Suitters et al, 1994) Bradykinin (Bachem, U.K.), was dissolved in saline containing 1% bovine serum albumin, and salbutamol hemisulphate salt (Sigma) was dissolved in saline containing ascorbic acid (1 mmol 1-1). The hamster murine chimeric anti-TNF monoclonal antibodies (TN3gl and TN3g2a, Suitters et al, 1994) (Celltech Therapeutics) were obtained in sterile antibody solution (TN3gl:-50 mM sodium acetate, 100 mM NaCl; TN3g2a:-50 mM sodium acetate) at pH 5.5.…”
Section: Regional Haemodynamicsmentioning
confidence: 99%
“…It binds both free and membranebound TNF, and causes apoptosis of TNF-producing cells [622]. Immune processes initiated by complement fixation and antibody-mediated cellular cytotoxicity are also possibly mediated by interaction with infliximab and TNF [623]. Infliximab is delivered intravenously; IBD patients typically receive an initial loading dose regimen of three infusions at weeks 0, 2, and 6, and subsequently receive maintenance infusions every 8 weeks (Fig.…”
Section: Infliximabmentioning
confidence: 99%
“…mAb 120.G8 (17) was obtained from Schering-Plough. Blocking hamster anti-murine TNF-␣ (TN3-19.12g1) (26,27) was provided by Celltech. mAbs to rat Ags, Ig (OX12), TCR-␣ (R73), CD6 (OX52), CD8 (OX8), CD45RA (OX33), CD103 (OX62), and CD172a (OX41), were purified from cell culture supernatants and used unconjugated or conjugated to FITC or biotin.…”
Section: Reagents and Mabsmentioning
confidence: 99%